Abstract | OBJECTIVE: CASE REPORT: A 62-year-old man developed severe bruxism that began 2 weeks after starting a therapy with venlafaxine because of depression and anxiety. After venlafaxine withdrawal, bruxism improved gradually and disappeared 2 months later. CONCLUSIONS:
|
Authors | Hortensia Alonso-Navarro, Manuela Martín-Prieto, Juan José Ruiz-Ezquerro, Félix Javier Jiménez-Jiménez |
Journal | Clinical neuropharmacology
(Clin Neuropharmacol)
2009 Mar-Apr
Vol. 32
Issue 2
Pg. 111-2
ISSN: 1537-162X [Electronic] United States |
PMID | 19512964
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antidepressive Agents, Second-Generation
- Cyclohexanols
- Venlafaxine Hydrochloride
|
Topics |
- Antidepressive Agents, Second-Generation
(adverse effects)
- Bruxism
(chemically induced)
- Cyclohexanols
(adverse effects, therapeutic use)
- Depression
(drug therapy)
- Humans
- Male
- Middle Aged
- Venlafaxine Hydrochloride
|